A meta-analysis of the prevalence of Toxoplasma gondii in animals and humans in Ethiopia

Gebremedhin, Endrias Zewdu; Tadesse, Getachew

doi:10.1186/s13071-015-0901-7

Parasites & Vectors

Table 1 Characteristics of the eligible studies

From: A meta-analysis of the prevalence of Toxoplasma gondii in animals and humans in Ethiopia

Author	Year of study	Location	Host	Method	Number	Positive (%)
Zewdu et al. [27]	2010–2011	CE	Goat	ELISA	927	183 (19.74)
Gebremedhin et al. [28]	2010–2011	CE	Sheep	ELISA	1030	357 (34.66)
Teshale [29]	2005–2006	CSE	Sheep, goat	MDAT	641	480 (74.88)
Demissie and Tilahun [30]	2000–2001	CE	Sheep, goat	MDAT	468	159 (33.97)
Negash et al. [31]	1999–2000	CE	Sheep, goat	MDAT/ELISA	174	75 (43.10)
Gebremedhin and Gizaw [32]	2013–2014	SE	Sheep, goat	ELISA	184	48 (26.09)
Gebremedhin et al. [33]	2011–2012	CE	Sheep, goat	DAT	628	111 (17.68)
Gebremedhin et al. [34]	2012–2013	CE	Camel	MAT	385	187 (48.57)
Tilahun et al. [35]	2012	CE	Chicken	MAT	125	48 (38.40)
Gebremedhin et al. [36]	2012–2013	CE	Chicken	MAT	601	183 (30.45)
Gebremedhin et al. [37]	2014	CE	Pig	DAT	402	129 (32.09)
Dubey [38]	2011	CE	Cat	MAT	36	33 (91.67)
Tiao [39]	2012	CE	Cat	MAT	48	41 (85.42)
Negash et al. [31]	1999–2000	CE	Cat	Coprology	40	5 (12.5)
Dubey [38]	2011	CE	Cat	Coprology	36	8 (22.22)
Mellbin and Vahlquist [40]	nr	WCSE	human	SFT	267	102 (38.20)
De Roever–Bonnet [41]	nr	CE	human	SFT	99	47 (47.47)
Guebre Xabier et al. [42]	1990	CSE	human	ELISA	919	673 (73.23)
Eshete et al. [43]	nr	CE	human	ELISA	94	19 (20.21)
Woldemichael et al.[44]	1995–1996	CE	human	SFT/LAT	340	268 (78.82)
Negash et al. [45]	1999–2000	CE	human	MDAT	65	39 (60.00)
Yimer et al. [46]	nr	CE	human	ELISA	279	270 (96.77)
Shibre et al. [47]^a	2005	CE	human	ELISA	90	80 (88.89)
Shimelis et al. [48]	2007	CE	human	ELISA	330	297 (90.00)
Tedla et al. [49]^a	2009	CE	human	ELISA	456	434 (95.18)
Zemene et al. [50]	2011	SE	human	ELISA	201	163 (81.09)
Gebremedhin et al. [51]	2010–2011	CE	human	ELISA	425	346 (81.41)
Aleme et al. [52]	2011–2012	CE	human	ELISA	150	141 (94.00)
Walle et al. [53]	nr	NE	human	ELISA	204	161 (78.92)
Muluye et al. [54]	2012–2013	NE	human	LAT	170	130 (76.47)
Tadesse et al. [55]	2012	NE	human	LAT	422	171 (40.52)
Endris et al. [56]	2010–2011	NE	human	LAT	385	341 (88.57)
Zeweld et al. [57]	2012–2013	NE	human	ELISA	651	51 (7.83)
Yohannes et al. [58]	2013	SE	human	ELISA	170	150 (88.24)

CE, Central Ethiopia; CSE, Central and Southern Ethiopia; DAT, direct agglutination test; ELISA, enzyme linked immunosorbent assay; LA, latex agglutination test; MAT, modified agglutination test; MDAT, modified direct agglutination test; MDAT/ELISA, modified direct agglutination test and enzyme linked immunosorbent assay; n, sample size; NE, Northern Ethiopia; nr, not reported; SE, Southern Ethiopia; SFT, Sabin-Feldman dye test; WCSE, Western, Central and Southern Ethiopia
^aData on T.gondii infection was collected before the trials

Back to article page

ISSN: 1756-3305

Contact us

Submission enquiries: journalsubmissions@springernature.com